Brand Lumigan (Bimatoprost) 0.03%
Lumigan Eye Drop contains bimatoprost as an active ingredient. It is used to treat a condition in which the pressure inside the eyes rises (glaucoma).�
Lumigan (Bimatoprost) 0.03% is a prescription eye drop used to lower elevated pressure inside the eye. It belongs to a class of medicines called prostaglandin analogs and is generally used to manage open-angle glaucoma or ocular hypertension.
Lumigan 0.03% contains bimatoprost, a synthetic prostaglandin analog, as its active ingredient. It is supplied as a sterile ophthalmic solution applied directly to the eye.
This medicine is generally prescribed when intraocular pressure needs to be reduced, either as an initial treatment or when other eye pressure-lowering medicines have not provided adequate control. It works locally within the eye rather than affecting the body as a whole.
Lumigan (Bimatoprost) 0.03% may be prescribed to:
Reduce elevated intraocular pressure in people with open-angle glaucoma
Reduce elevated intraocular pressure in people with ocular hypertension
The appropriate treatment plan and dosing schedule should be determined by an eye care professional based on individual eye pressure readings and overall eye health.
Lumigan works by increasing the outflow of the fluid inside the eye (aqueous humor) through the eye's natural drainage pathways. By helping this fluid drain more efficiently, it reduces the pressure that builds up inside the eye, which can otherwise damage the optic nerve over time.
The eye pressure-lowering effect generally begins within a few hours of application, with the fullest effect typically seen with consistent, ongoing use.
Take Lumigan exactly as prescribed by your healthcare professional.
Usually applied as one drop in the affected eye(s) once daily, generally in the evening
Wash your hands before use and avoid letting the dropper tip touch the eye or surrounding skin
If you wear contact lenses, remove them before applying the drops and wait before reinserting, as advised by your eye care professional
If using other eye drops at the same time, space them at least five minutes apart
Do not stop or change your treatment without professional advice, as untreated eye pressure can worsen without noticeable symptoms
If a dose is missed, apply it as soon as remembered unless it is close to the time for the next dose, in which case the missed dose should be skipped. Do not apply extra drops to make up for a missed one.
Tell your doctor or pharmacist about your full medical history and all medicines, supplements, and herbal products you currently use before starting Lumigan.
Caution may be needed if you have:
Active inflammation inside the eye (such as uveitis)
A history of macular edema, or risk factors for it (including certain types of cataract surgery)
Narrow-angle, inflammatory, or neovascular glaucoma
Dry eye or other chronic eye surface conditions
Lumigan is generally not recommended for use with other prostaglandin analog eye drops, and its effects alongside other eye medicines should be reviewed by a professional. Check possible interactions with a doctor or pharmacist before combining Lumigan with any other eye treatments.
The safety of Lumigan during pregnancy has not been established in humans, and it is generally used only if the potential benefit is considered to outweigh potential risk. It is not known whether bimatoprost passes into human breast milk, so caution is generally advised during breastfeeding. Recommendations may vary, so speak with your doctor or pharmacist if you are pregnant, planning a pregnancy, or breastfeeding.
Like all medicines, Lumigan can cause side effects, although not everyone experiences them.
Common side effects include:
Eye redness
Itching, burning, or stinging in the eye
A feeling of something in the eye
Dry eyes or excessive watering
Gradual darkening of the iris (colored part of the eye) or eyelid skin, and changes in eyelash length, thickness, or number, with long-term use
Seek prompt medical attention if you experience sudden vision changes, significant eye pain, or swelling and redness that seems more than mild irritation.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Lumigan according to the instructions shown on the original product packaging.
Keep the bottle tightly closed when not in use
Protect from excessive heat
Keep out of reach of children
Do not use after the expiry date, or beyond the discard period noted on the packaging after first opening
Lumigan is used to lower elevated pressure inside the eye in people with open-angle glaucoma or ocular hypertension.
The eye pressure-lowering effect generally begins within a few hours of application, though full benefit develops with regular, ongoing use.
With long-term use, some people notice a gradual darkening of the iris, which may be permanent. This should be discussed with your eye care professional.
Yes, gradual changes such as longer, thicker, or more numerous eyelashes have been reported with continued use, and these changes are often reversible after stopping treatment.
No. Glaucoma and ocular hypertension usually require ongoing treatment, and stopping without medical advice can allow eye pressure to rise again.
Contact lenses should generally be removed before applying the drops and can usually be reinserted after a short interval, as advised by your eye care professional.
Generic bimatoprost contains the same active ingredient and is expected to work the same way, though inactive ingredients and packaging may differ.